Filed before 2025Filed 14 March 2018
Arrogene, Inc raised $2.71M
Arrogene, Inc, a biotech company based in Los Angeles, CA, raised $2.71M in a new equity round, according to a filing dated 14 March 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 14 March 2018
- Round
- Equity round
- Amount sold
- $2.71M
- Offering size
- $2.76M
- Investors so far
- 43
- Based in
- Los Angeles, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 29% of the 1,729 tracked raises with an amount filed in 2018, and than 24% of the 160 in biotech.
Arrogene, Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 30 Oct 2019 | New filing | $10K | Another raise |
| 8 May 2018 | New filing | $525K | Another raise |
| 14 Mar 2018 | New filing | $2.71M | This raise |
More with Multiverse Investment on the board
- Black Light Surgical, Inc.$2.05M
- Nanotech Energy, Inc.$28.2M
- NeuroVision Imaging, Inc.$11.2M
- Materia, Inc.$14.9M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.